English
|
正體中文
|
简体中文
|
全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 909383 在线人数 : 718
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
搜寻范围
全部NHRI
生技與藥物研究所
謝興邦
--期刊論文
查询小技巧:
您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
进阶搜寻
主页
‧
登入
‧
上传
‧
说明
‧
关于NHRI
‧
管理
國家衛生研究院 NHRI
>
生技與藥物研究所
>
謝興邦
>
期刊論文
>
依题名浏览
依作者浏览
依日期浏览
依数据类型浏览
数据加载中.....
邻近类别
會議論文/會議摘要
[
30
/48]
專利
[
0
/42]
类别统计
近3年内发表的文件:12(8.51%)
含全文笔数:141(100.00%)
文件下载次数统计
下载大于0次:141(100.00%)
下载大于100次:138(97.87%)
全文下载总次数:83978(82.42%)
最后更新时间: 2024-12-01 00:40
上传排行
数据加载中.....
下载排行
数据加载中.....
最近上传
DBPR116, a prodrug of BPRMU191, in ...
Discovery of dual MER/AXL kinase in...
Macrophage-mediated controlled rele...
Targeting cathepsin S promotes acti...
Influence of ring strain on the for...
A dual nociceptin and mu opioid rec...
Development of furanopyrimidine-bas...
A critical overview of current prog...
Recent advances in total synthesis ...
Natural product myricetin is a pan-...
跳至:
(选择年份)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(选择月份)
January
February
March
April
May
June
July
August
September
October
November
December
或输入年份:
由新到旧排序
由最旧的开始
显示项目76-100 / 141. (共6页)
<<
<
1
2
3
4
5
6
>
>>
每页显示[
10
|
25
|
50
]项目
日期
题名
關聯
2010-09
Cancer cells acquire mitotic drug resistance properties through beta i-tubulin mutations and alterations in the expression of beta-tubulin isotypes
PLoS ONE. 2010 Sep;5(9):Article number e12564.
2010-07
Antiangiogenic Activities and Cisplatin-combined Antitumor Activities of BPR0L075
Anticancer Research. 2010 Jul;30(7):2813-2822.
2010-06-15
Fast-forwarding hit to lead: Aurora and epidermal growth factor receptor kinase inhibitor lead identification
Journal of Medicinal Chemistry. 2010 Jun 15;53(13):4980-4988.
2010-06
Design and synthesis of alpha-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis
Journal of Medicinal Chemistry. 2010 Jun;53(11):4545-4549.
2010-03-11
5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors
Journal of Medicinal Chemistry. 2010 Mar 11;53(5):2309-2313.
2010-02-25
Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives
Journal of Medicinal Chemistry. 2010 Feb 25;53(4):1519-1533.
2010-02-23
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity
Journal of Biomedical Science. 2010 Feb 23;17:Article number 13.
2010-02-01
Identification, SAR studies, and X-ray Co-crystallographic analysis of a novel furanopyrimidine aurora kinase a inhibitor
ChemMedChem. 2010 Feb 1;5(2):255-267.
2010-02
Comparative molecular field analysis of anti-tubulin agents with indole ring binding at the colchicine binding site
Journal of Theoretical and Computational Chemistry. 2010 Feb;9(1):279-291.
2010-01
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses
Journal of Antimicrobial Chemotherapy. 2010 Jan;65(1):63-71.
2009-08-13
Synthesis and evaluation of 3-aroylindoles as anticancer agents: Metabolite approach
Journal of Medicinal Chemistry. 2009 Aug 13;52(15):4941-4945.
2009-07-23
Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity
Journal of Medicinal Chemistry. 2009 Jul 23;52(14):4221-4233.
2009-07-03
Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers
Molecular Cancer. 2009 Jul 3;8:Article number 43.
2009-04-24
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
Journal of Biological Chemistry. 2009 Apr 24;284(17):11121-11133.
2009-04-23
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists
Journal of Medicinal Chemistry. 2009 Apr 23;52(8):2618-2622.
2009-04-17
Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents
ChemMedChem. 2009 Apr 17;4(4):588-593.
2009-04
Aurora kinase inhibitors in preclinical and clinical testing
Expert Opinion on Investigational Drugs. 2009 Apr;18(4):379-398.
2009-03
Advances in Aurora kinase inhibitor patents
Expert Opinion on Therapeutic Patents. 2009 Mar;19(3):321-356.
2009-02-26
Structure-based drug design of novel aurora kinase a inhibitors: Structural basis for potency and specificity
Journal of Medicinal Chemistry. 2009 Feb 26;52(4):1050-1062.
2009-02
Aurintricarboxylic acid inhibits influenza virus neuraminidase
Antiviral Research. 2009 Feb;81(2):123-131.
2008-12-25
Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents
Journal of Medicinal Chemistry. 2008 Dec 25;51(24):8163-8167.
2008-07-24
Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors
Journal of Medicinal Chemistry. 2008 Jul;51(14):4351-4355.
2008-07
Anti-HSV activity of digitoxin and its possible mechanisms
Antiviral Research. 2008 Jul;79(1):62-70.
2008-06-01
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors
Analytical Biochemistry. 2008 Jun;377(1):89-94.
2008-05
Bioassay-guided purification and identification of PPARa/gamma agonists from Chlorella sorokiniana
Phytotherapy Research. 2008 May;22(5):605-613.
显示项目76-100 / 141. (共6页)
<<
<
1
2
3
4
5
6
>
>>
每页显示[
10
|
25
|
50
]项目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回馈